Category Archives: U-2

Kaempferol

Cancer:
Pancreatic, osteosarcoma, metastasis, ovarian cancer

Action: Anti-oxidation, anti-inflammatory, cell-cycle arrest, blood sugar regulation, estrogen receptor modulator, metastasis

Kaempferol is a flavonol compound present in various plants and Chinese medicinal herbs, including Allium cepa (L.).

Blood Sugar Regulation

It has been found that kaempferol, a flavonol compound present in various Chinese medicinal herbs, has cyto-protective effects on cultured clonal beta-cells and pancreatic human islets. Kaempferol treatment dose-dependently promoted viability, inhibited cellular apoptosis, and reduced caspase-3 activity in beta-cells and human islets exposed to chronic high glucose, with 10 µM kaempferol exerting the maximum effect. In addition, kaempferol treatment improved the expression of anti-apoptotic proteins Akt and Bcl-2, that was significantly reduced in beta-cells and human islets chronically exposed to hyperglycemia.

Furthermore, exposure of beta-cells and human islets to kaempferol restored high glucose-attenuated intracellular cAMP and ATP production. Inhibition of protein kinase A or Akt activation ablated the anti-apoptotic effect of kaempferol. These cytoprotective effects of kaempferol were associated with improved insulin secretory function and synthesis in beta-cells and human islets.

These findings provide evidence that kaempferol may be a naturally occurring anti-diabetic compound through protecting pancreatic beta-cell survival and function in a hostile environment that would otherwise lead to type 2 diabetes (Zhang et al., 2011).

Ovarian Cancer

Recent studies indicate that apigenin, genistein, kaempferol, luteolin, and quercetin potently inhibit VEGF production and suppress ovarian cancer cell metastasis in vitro. Unlike NSAIDS (non-steroid anti-inflammatory drugs), well-documented clinical data for phyto-active compounds are lacking. In order to evaluate objectively the potential benefit of these compounds in the treatment of ovarian cancer, strategically designed, large scale studies are warranted (Chen et al., 2012).

Estrogen Receptor Modulator

Kaempferol is a dietary flavonoid that can function as a selective estrogen receptor modulator (SERM). Estrogen-related receptors alpha and gamma (ERR α and ERRγ) are orphan nuclear receptors that play important roles in mitochondrial biogenesis and cancer development. Wang, Gao, & Wang (2013) have shown that kaempferol can functionally antagonize the activities of ERRs based on both response element reporter systems and target gene analysis. Kaempferol modulation of mitochondrial function and suppression of cancer cell growth has been confirmed. These findings suggest that kaempferol may exert its anti-cancer activities through antagonizing ERRs activity.

Osteosarcoma; Metastasis

Kaempferol displayed inhibitory effects on the invasion and adhesion of U-2 osteosarcoma (OS) cells in a concentration-dependent manner and it also inhibited the migration of U-2 OS cells in a concentration-dependent manner. Kaempferol treatment reduced the enzymatic activities and protein levels of matrix metalloproteinase (MMP)-2, MMP-9 and urokinase plasminogen activator (uPA) and furthermore, kaempferol was able to reduce the protein phosphorylation of ERK, p38 and JNK. Results suggest a potential role for kaempferol in the therapy of tumor metastasis of OS (Chen et al., 2013).

Cell-cycle Arrest

Kaempferol decreased cell viability as determined by MTT assays and induced a G2/M phase cell-cycle arrest in a concentration-dependent manner. CDK1/cyclin B expression and the AMPK and AKT signaling pathways contributed to kaempferol-induced G2/M cell-cycle arrest and autophagic cell death in SK-HEP-1 human hepatic cancer cells (Huang et al., 2013).

References

Chen SS, Michael A, Butler-Manuel SA. (2012). Advances in the treatment of ovarian cancer: a potential role of anti-inflammatory phytochemicals. Discov Med, 13(68):7-17.


Chen HJ, Lin CM, Lee CY, et al. (2013). Kaempferol suppresses cell metastasis via inhibition of the ERK-p38-JNK and AP-1 signaling pathways in U-2 OS human osteosarcoma cells. Oncol Rep, 30(2):925-32. doi: 10.3892/or.2013.2490.


Huang WW, Tsai SC, Peng SF, et al. (2013). Kaempferol induces autophagy through AMPK and AKT signaling molecules and causes G2/M arrest via down-regulation of CDK1/cyclin B in SK-HEP-1 human hepatic cancer cells. Int J Oncol, 42(6):2069-77. doi: 10.3892/ijo.2013.1909.


Wang H, Gao M, Wang J. (2013). Kaempferol inhibits cancer cell growth by antagonizing estrogen-related receptor α and γ activities. Cell Biol Int. doi: 10.1002/cbin.10152.


Zhang Y, Liu D. (2011). Flavonol kaempferol improves chronic hyperglycemia-impaired pancreatic beta-cell viability and insulin secretory function. Eur J Pharmacol, 670(1):325-32. doi: 10.1016/j.ejphar.2011.08.011.